Tata Group To Launch FELUDA – India’s First CRISPR-Based COVID-19 Test : Approved By DGCI

Like
Like Love Haha Wow Sad Angry

India’s CRISPR-based COVID Test – FELUDA Covid-19 Test The Drugs Controller General of India has approved the commercial launch of an indigenously developed test that uses the cutting-edge CRISPR gene-editing technology and is affordable, quick, and accurate in detecting the COVID-19 causing virus, the SARS-CoV-2 virus. This CRISPR-based COVID-19 test named Feluda, a paper-strip COVID-19 […]

The post Tata Group To Launch FELUDA – India’s First CRISPR-Based COVID-19 Test : Approved By DGCI appeared first on BioTecNika .Read more at  www.biotecnika.org/2020/09/india-crispr-based-covid-test-feluda-covid-19-test/

Like
Like Love Haha Wow Sad Angry